By Frank Prenesti
Date: Thursday 10 Oct 2024
(Sharecast News) - FTSE 250 (MCX) 20,723.35 -0.48%
Shares in Indivior plunged on Thursday after the pharma group cut its full-year revenue forecast for the second times following a weaker-than-expected third-quarter performance from Sublocade, its treatment of moderate to severe opioid use disorder.
The company said it...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news